Although HCoV-NL63 shares the same host receptor (ACE2) as SARS-CoV-2, it typically causes mild, self-limiting upper respiratory tract infections and, occasionally, more severe lower respiratory tract infections [67,68]. This evidence concerns the gene ACE2 and Recurrent lower respiratory tract infections.